Kofnix SR Tablet
Butamirate Citrate
50mg
ACI Limited
| Pack size | 30's pack |
|---|---|
| Dispensing mode | |
| Source | |
| Agent | |
| Retail Price | 10.03 AED |
Available as:
Indications
Kofnix SR Tablet is used for:
Cough (non-productive), Whooping cough, Pre-post operative cough, Cough suppression
Adult Dose
Tablet: Adolescents over 12 years old: 1-2 tablets daily.
Adults: 2-3 tablets daily at 8 to 12 hours intervals.
Syrup: Adult: 15 ml 4 times daily; Adolescent: 15 ml 4 times daily
Child Dose
Tablet:
Adolescents over 12 years old: 1-2 tablets daily.
Syrup:
Children (6-12 years): 10 ml 3 times daily,
Children (3-6 years): 5 ml 3 times daily.
Paediatric drops:
Infants (2 months - 1 year): 10 drops four times daily;
Infants (1 - 3 years): 15 drops four times daily.
Renal Dose
Administration
Contra Indications
Hypersensitivity.
Precautions
Pregnancy and lactation.
Pregnancy-Lactation
Interactions
Concomitant use of expectorants may lead to retention of mucous in the resp system, which can increase the risk of bronchospasm and airway infection.
Adverse Effects
Side effects of Butamirate Citrate :
Rarely, skin rash, nausea, diarrhoea or dizziness.
Mechanism of Action
Butamirate is reported to have a central action that is used as a cough suppressant in non-productive cough.
Note
Kofnix 50mg SR Tablet manufactured by ACI Limited. Its generic name is Butamirate Citrate. Kofnix is availble in Bangladesh.
Farmaco BD drug index information on Kofnix SR Tablet is not intended for diagnosis, medical advice or treatment; neither intended to be a substitute for the exercise of professional judgment.